AAAAAA

   
Results: 1-6 |
Results: 6
CHYLOMICRON METABOLISM IS ALTERED IN OVARIAN-CARCINOMA
Authors: GRAZIANI SR MARANHAO RC BRANDIZZI LI VINAGRE CG HEGG R AMANCIO RF
Citation: Sr. Graziani et al., CHYLOMICRON METABOLISM IS ALTERED IN OVARIAN-CARCINOMA, Annals of oncology, 9, 1998, pp. 643-643
NAVELBINE (NVB), AND FRACTIONATED DOSE DOXORUBICIN (DX) IMPROVES FIRST LINE ADVANCED BREAST-CANCER (ABC) CHEMOTHERAPY - AN OVERVIEW OF 3 PHASE-II TRIALS
Authors: CARMICHAEL J HEGG R FIRAT D PAWLICKI M LEBRAS F DANEL P DELGADO FM
Citation: J. Carmichael et al., NAVELBINE (NVB), AND FRACTIONATED DOSE DOXORUBICIN (DX) IMPROVES FIRST LINE ADVANCED BREAST-CANCER (ABC) CHEMOTHERAPY - AN OVERVIEW OF 3 PHASE-II TRIALS, European journal of cancer, 33, 1997, pp. 649-649
NAVELBINE (NVB) AND DOXORUBICIN (DX) BOTH AT 25 MG M(2), ON DAY-1 ANDDAY-8 FOR THE MANAGEMENT OF ADVANCED BREAST-CANCER (ABC)/
Authors: ANELLI A HEGG R COSTA MA CORREA M YAMAGUCHI N NOVAES NMV ANDRADE CA RODRIGUES T MALZYNER A ALTINO J CAPONERO R CABRAL S PERDICARIS M DELGADO GL PIZZANELLI M DELGADO FM
Citation: A. Anelli et al., NAVELBINE (NVB) AND DOXORUBICIN (DX) BOTH AT 25 MG M(2), ON DAY-1 ANDDAY-8 FOR THE MANAGEMENT OF ADVANCED BREAST-CANCER (ABC)/, European journal of cancer, 33, 1997, pp. 670-670
DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/
Authors: BRUFMAN G COLAJORI E GHILEZAN N LASSUS M MARTONI A PEREVODCHIKOVA N TOSELLO C VIARO D ZIELINSKI C KRAINER M SALZER H SCHULLER J DITTRICH C SCHEITHAUER W ZAMAGNI C AMBROSINI G COLUCCI G GENTILINI P ZANIBONI A PACINI P BIANCO R MUSTACCHI G DAPRILE M DEMATTEIS A OLIVEIRA C JORDAAN J GUDGEON A VANZYL J RAKOWSKY E INBAR M RATH P COHEN Y SHANI A FRIED G HEGG R NETO AB BADER G BRAGA RF VITOC C PUERTO VML VALLE AE SALAZAR JD SANCHEZ JC VILLELA GM FOUNTZILAS G
Citation: G. Brufman et al., DOUBLING EPIRUBICIN DOSE INTENSITY (100 MG M(2) VERSUS 50 MG/M(2)) INTHE FEC REGIMEN SIGNIFICANTLY INCREASES RESPONSE RATES - AN INTERNATIONAL RANDOMIZED PHASE-III STUDY IN METASTATIC BREAST-CANCER/, Annals of oncology, 8(2), 1997, pp. 155-162
THE EFFECTS OF PRIMARY CHEMOTHERAPY ON THE COMPLEXITY OF BREAST-CANCER SURGICAL-TREATMENT
Authors: HEGG R RUIZ CA REZENDE WW TEIXEIRA LC BARROS ACSD NISIDA ACT PINOTTI JA AGUIAR IF
Citation: R. Hegg et al., THE EFFECTS OF PRIMARY CHEMOTHERAPY ON THE COMPLEXITY OF BREAST-CANCER SURGICAL-TREATMENT, European journal of cancer, 31A, 1995, pp. 1033-1033
PHASE-II TRIAL OF WEEKLY IV VINORELBINE AS A SINGLE-AGENT IN FIRST-LINE ADVANCED BREAST-CANCER CHEMOTHERAPY - THE LATIN-AMERICAN EXPERIENCE
Authors: BRUNO S PUERTO VL MICKIEWICZ E HEGG R TEXEIRA LC GAITAN L MARTINEZ L FERNANDEZ O OTERO J KESSELRING G NOGUERA C DELGADO G GAUBERT P DELGADO FM SOLIDORO A
Citation: S. Bruno et al., PHASE-II TRIAL OF WEEKLY IV VINORELBINE AS A SINGLE-AGENT IN FIRST-LINE ADVANCED BREAST-CANCER CHEMOTHERAPY - THE LATIN-AMERICAN EXPERIENCE, American journal of clinical oncology, 18(5), 1995, pp. 392-396
Risultati: 1-6 |